How practical is the application of percutaneous nephrolithotomy scoring systems? Prospective study comparing Guy’s Stone Score, S.T.O.N.E. score and the Clinical Research Office of the Endourological Society (CROES) nomogram
Abstract:ObjectiveTo prospectively compare the Guy’s Stone Score (GSS), S.T.O.N.E. [stone size (S), tract length (T), obstruction (O), number of involved calices (N), and essence or stone density (E)] score and the Clinical Research Office of the Endourological Society (CROES) nephrolithometric nomogram to predict percutaneous nephrolithotomy (PCNL) success rate and assess the correlation with perioperative complications.Patients and methodsWe prospectively evaluated all consecutive PCNL patients at our institute betwe… Show more
“…In a large multicentre comparative study, Tailly et al [25] showed that all three scoring systems were equally predictive of post‐PCNL SFS. In a small prospective study cohort, Singla et al [26] performed a similar comparison and drew a similar conclusion. A extensive literature survey showed that Noureldin et al [27] favoured GSS and the STONE score for their significant associations with SFS, whereas Bozkurt et al [28] suggested that GSS and the CROES nomogram were significantly associated with SFS.…”
Section: Discussionmentioning
confidence: 63%
“…However, Vicentini et al [35] showed that GSS was associated with post‐PCNL complications. Singla et al [26] found weak correlation of modified Clavien–Dindo grades with the scoring systems.…”
To evaluate which among the three scoring systems used to predict stone-free status (SFS) after percutaneous nephrolithotomy (PCNL), namely Guy's stone score (GSS), STONE nephrolithometry score and Clinical Research Office of the Endourological Society (CROES) nephrolithometry nomogram, is the most accurate predictor of SFS. Method and Materials We prospectively included all patients who underwent PCNL (tract size >24 F) at our hospital between July 2017 and January 2019. All demographic and peri-operative data were tabulated including calculation of GSS, STONE score and CROES nomogram score using preoperative computed tomography. Comparison of the 'stone-free' group and 'residualstone' group was carried out using standard statistical methods. Results A total of 252 patients were enrolled. The mean GSS, STONE score and CROES score in the stone-free group was 1.60, 6.98 and 212.27, respectively, and in the residual stone group group it was 2.93, 8.98 and 129.89, respectively (P < 0.001 in each). Receiver-operating characteristic (ROC) curves showed that all three scoring systems had similar predictive accuracy for post-PCNL SFS, with STONE score having the highest area under the ROC curve value (0.852). GSS was significantly associated with operating time, estimated blood loss (EBL) and length of hospital stay (LOS; P < 0.001 in each). STONE score and CROES score were both significantly associated with EBL (P = 0.029 and 0.001, respectively). Conclusion All three scoring systems are equally predictive of post-PCNL SFS. EBL is significantly associated with all three scoring systems, while GSS is also associated with operating time and LOS.
“…In a large multicentre comparative study, Tailly et al [25] showed that all three scoring systems were equally predictive of post‐PCNL SFS. In a small prospective study cohort, Singla et al [26] performed a similar comparison and drew a similar conclusion. A extensive literature survey showed that Noureldin et al [27] favoured GSS and the STONE score for their significant associations with SFS, whereas Bozkurt et al [28] suggested that GSS and the CROES nomogram were significantly associated with SFS.…”
Section: Discussionmentioning
confidence: 63%
“…However, Vicentini et al [35] showed that GSS was associated with post‐PCNL complications. Singla et al [26] found weak correlation of modified Clavien–Dindo grades with the scoring systems.…”
To evaluate which among the three scoring systems used to predict stone-free status (SFS) after percutaneous nephrolithotomy (PCNL), namely Guy's stone score (GSS), STONE nephrolithometry score and Clinical Research Office of the Endourological Society (CROES) nephrolithometry nomogram, is the most accurate predictor of SFS. Method and Materials We prospectively included all patients who underwent PCNL (tract size >24 F) at our hospital between July 2017 and January 2019. All demographic and peri-operative data were tabulated including calculation of GSS, STONE score and CROES nomogram score using preoperative computed tomography. Comparison of the 'stone-free' group and 'residualstone' group was carried out using standard statistical methods. Results A total of 252 patients were enrolled. The mean GSS, STONE score and CROES score in the stone-free group was 1.60, 6.98 and 212.27, respectively, and in the residual stone group group it was 2.93, 8.98 and 129.89, respectively (P < 0.001 in each). Receiver-operating characteristic (ROC) curves showed that all three scoring systems had similar predictive accuracy for post-PCNL SFS, with STONE score having the highest area under the ROC curve value (0.852). GSS was significantly associated with operating time, estimated blood loss (EBL) and length of hospital stay (LOS; P < 0.001 in each). STONE score and CROES score were both significantly associated with EBL (P = 0.029 and 0.001, respectively). Conclusion All three scoring systems are equally predictive of post-PCNL SFS. EBL is significantly associated with all three scoring systems, while GSS is also associated with operating time and LOS.
“…scores correlated with complications, whereas Tailly et al [18] found that none of them correlated with complications. Tailly et al [18] also found that all three could predict residual fragments and were equivalent; this was also observed by Singla et al [26]. Both of these authors found S.T.O.N.E.…”
Objective: (a) To assess the inter-observer variability amongst surgeons performing percutaneous nephrolithotomy (PCNL) and radiologists for the Guy's Stone Score (GSS) and S.T.O.N.E. (stone size [S], tract length [T], obstruction [O], number of involved calyces [N], and essence or stone density [E]) nephrolithometry score; (b) To determine which scoring system of the two is better for predicting the stone-free rate (SFR) after PCNL. Patients, subjects and methods: Patients undergoing PCNL between February 2016 and September 2016 were prospectively enrolled. Preoperative computed tomography was done in all patients. The GSS and S.T.O.N.E. nephrolithometry score were independently calculated by eight surgeons and four radiologists. The patients were operated on by one of the surgeons (all were consultants). The Fleiss' κ coefficient was used to assess agreement independently between the surgeons and radiologists. Receiver operating characteristic (ROC) curves were constructed for predicting the SFR using the average of the scores of the surgeons and radiologists separately. Results: A total of 157 patients underwent PCNL. The SFR was 71.3% (112/157 patients). The Fleiss' κ scores ranged from 0.51 to 0.88 (overall 0.79) for the S.T.O.N.E. score and 0.53-0.91 for the GSS, suggesting moderate to very good agreement. The ROC curve for the S.T.O.N. E. nephrolithometry scores of surgeons (area under the curve [AUC] = 0.806) as well as the radiologists (AUC = 0.810) had a higher predictive value for the SFR than the GSS of the surgeons (AUC = 0.738) and the radiologists (AUC = 0.747). Conclusion: There is overall good agreement between surgeons and radiologists for both the GSS and S.T.O.N.E. nephrolithometry score. The S.T.O.N.E. score had a higher predictive value for the SFR than the GSS.
“…This is higher than that reported by Singla et al ., Shalaby et al ., and Falahatkar et al . at 62.2%, 74.8%, and 76.2%, respectively,[181920] and lower than that reported by Tefekli et al ., 81.6%. [5] Two studies published in 2017 showed identical results regarding stone resolution rates (92%), which is significantly higher when compared to our result.…”
Introduction:Percutaneous nephrolithotomy (PCNL) is still the mainstay and the treatment of choice for most complex renal stones. The success of PCNL is defined by achieving a stone-free rate (SFR). Lower calyceal access PCNL is established to be the safest percutaneous access to the renal system, but controversy is present when it comes to SFR in comparison to upper calyceal and middle calyceal accesses.Aim:We aim to prove that lower calyceal access PCNL is the safest PCNL access and has the same efficacy as upper calyceal access PCNL for staghorn stones.Methodology:All lower calyceal access PCNLs done from May 2012 to August 2017 were included in the study. Postoperative complications were reported using the modified Clavien Grading System.Results:Sixty-seven patients were included in the study. The mean age was found to be 49.39 years; most (36 [53.73%]) patients were male. The prevalence of diabetes, hypertension, dyslipidemia, and chronic kidney disease was 40.91%, 47.76%, 37.31%, and 20.00%, respectively. The mean hospital stay was 7.9 days; mean operative time was 138.52 min. The mean staghorn stone burden was 476.34 mm2. About 80.59% (n = 54) of patients had complete stone resolution after the first session. Only 3 (4.47%) patients had complications and classified as Grade 2 on the modified Clavien Grading System and the remainder were classified as Grade 1, two patients needed postoperative blood transfusion, and one had a renal pelvis perforation.Conclusion:When it comes to safety and efficacy, the use of lower calyceal single-access PCNL has a very low complication rate compared to upper calyceal access PCNL, especially pneumothorax and bleeding.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.